QUEST DIAGNOSTICS INC (DGX) Options Risk Score
Real-time risk analysis for DGX options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full DGX options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan DGX Now — Free →
Is it risky to sell options on QUEST DIAGNOSTICS INC (DGX) right now?
QUEST DIAGNOSTICS INC (DGX) currently scores 59 out of 100 for options catalyst risk (MEDIUM) over a 4-week expiry window. That score is driven by 14 recent news items, 2 active legal filings, 1 recent SEC event and 13 clinical-trial catalysts falling inside the 4-week window. On TickerRisk's scale 45 to 69 is MEDIUM, meaning something in the 4-week window is worth checking before committing to an expiry. The score measures scheduled event exposure, not the direction DGX will move.
DGX shows an IV Rank of 58, putting implied volatility in the middle of its one-year range — options are moderately priced, with a current implied volatility of about 32%. IV Rank answers how DGX options are priced against their own history, which is the starting point for choosing between selling and buying premium.
DGX does not report again until 2026-07-23, so near-dated expiries avoid it; the stock has moved up 7.3% recently.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer